Methotrexate vs 6‐mercaptopurine
Maintenance of clinical remission · Participants with Crohn's disease in remission
It is very uncertain whether methotrexate changes proportion of patients maintaining clinical remission compared with 6‐mercaptopurine (very low certainty).
1 finding from 1 review
- RR 1.36 [0.92, 2]2 studies · 50 participantsVery low